ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 3593

$1.41M Total Retail Price of All Prescriptions

Rank: 61 out of 3593

681 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 681 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 681 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 22,958 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 913 834 1 1
FUROSEMIDE 878 814 2 9
AMLODIPINE BESYLATE 817 756 3 3
LISINOPRIL 666 603 4 2
LEVOTHYROXINE SODIUM 657 610 5 4
WARFARIN SODIUM 609 470 6 18
POTASSIUM CHLORIDE 557 508 7 24
METOPROLOL TARTRATE 556 486 8 8
METFORMIN HCL 471 416 9 6
DONEPEZIL HCL 427 418 10 31
MIRTAZAPINE 419 370 11 64
PRAVASTATIN SODIUM 404 365 12 13
SERTRALINE HCL 371 289 13 28
CITALOPRAM HBR 370 307 14 25
HYDROCODONE-ACETAMINOPHEN 363 293 S3 15 7
ATORVASTATIN CALCIUM 356 322 16 15
CARVEDILOL 345 291 17 23
DIVALPROEX SODIUM 342 297 18 121
GABAPENTIN 338 250 19 16
CLOPIDOGREL 322 296 20 30
ATENOLOL 317 277 21 11
RISPERIDONE 312 255 22 83
HYDROCHLOROTHIAZIDE 310 272 23 10
NAMENDA 277 258 24 50
RAMIPRIL 276 237 25 92
GLIPIZIDE 254 241 26 40
CLONIDINE HCL 245 196 27 41
OMEPRAZOLE 242 165 28 5
LANTUS 227 205 29 57
TAMSULOSIN HCL 212 165 30 33
TRAMADOL HCL 207 184 31 17
ISOSORBIDE MONONITRATE ER 199 186 32 61
IPRATROPIUM-ALBUTEROL 198 195 33 154
NOVOLIN R 198 164 33 140
LOSARTAN POTASSIUM 196 194 35 14
PLAVIX 195 186 36 42
ESCITALOPRAM OXALATE 188 176 37 71
TRAZODONE HCL 185 159 38 53
SINGLE USE SWAB 176 141 39 311
ZOLPIDEM TARTRATE 175 131 40 12
METOPROLOL SUCCINATE 173 135 41 19
NYSTATIN 167 141 42 167
SANTYL 156 146 43 208
ALENDRONATE SODIUM 153 150 44 22
CRESTOR 146 133 45 21
PAROXETINE HCL 141 119 46 62
OXYCODONE-ACETAMINOPHEN 134 94 S2 47 93
INSULIN SYRINGE 127 99 48 91
SULFAMETHOXAZOLE-TRIMETHOPRIM 127 106 48 102
DIGOXIN 124 107 50 58
DIOVAN 124 97 50 46
CARBIDOPA-LEVODOPA 117 115 52 135
ACETAMINOPHEN-CODEINE 116 89 S3 53 153
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 91 54 26
ALBUTEROL SULFATE 114 111 54 157
CYMBALTA 114 91 54 73
PREDNISONE 108 101 57 49
CIPROFLOXACIN HCL 106 94 58 52
AZITHROMYCIN 101 93 59 34
LOSARTAN-HYDROCHLOROTHIAZIDE 100 94 60 48
PANTOPRAZOLE SODIUM 98 95 61 45
PERMETHRIN 95 88 62 347
MORPHINE SULFATE ER 95 60 S2 62 108
ALLOPURINOL 94 91 64 35
ADVAIR DISKUS 91 79 65 47
NITROSTAT 91 82 65 224
FENOFIBRATE 90 90 67 39
LEVETIRACETAM 90 70 67 127
CLOTRIMAZOLE-BETAMETHASONE 88 77 69 94
TRIAMTERENE-HCTZ 84 76 70 66
QUETIAPINE FUMARATE 84 74 70 89
KLOR-CON M20 81 81 72 139
LEVEMIR 81 49 72 193
LATANOPROST 79 79 74 195
FENTANYL 78 78 S2 75 137
NOVOLIN N 78 78 75 340
SPIRONOLACTONE 77 55 77 86
VALPROIC ACID 76 52 78 359
SPIRIVA 75 73 79 87
PHENYTOIN SODIUM EXTENDED 75 64 79 165
GLIPIZIDE ER 71 69 81 101
NITROFURANTOIN MONO-MACRO 71 58 81 242
LEVOFLOXACIN 71 70 81 116
VERAPAMIL ER 70 57 84 99
MUPIROCIN 69 64 85 132
CEFTRIAXONE 68 66 86 301
FINASTERIDE 68 68 86 79
FLUTICASONE PROPIONATE 66 57 88 32
LEXAPRO 65 61 89 184
CALCITONIN-SALMON 64 51 90 307
BENICAR 64 54 90 131
MELOXICAM 64 58 90 29
NIFEDIPINE ER 63 61 93 75
OLANZAPINE 63 53 93 198
LYRICA 62 56 95 105
GLYBURIDE 62 44 R 95 55
BACLOFEN 59 11 97 109
ALPRAZOLAM 59 40 97 37
ARANESP 58 58 99 569
TRIAMCINOLONE ACETONIDE 57 51 100 119
DIVALPROEX SODIUM ER 57 57 100 256
ABILIFY 56 52 102 162
DOXYCYCLINE HYCLATE 56 42 102 141
CYCLOBENZAPRINE HCL 56 28 R 102 72
NOVOLIN 70-30 55 41 105 146
RISPERDAL CONSTA 55 55 105 389
SINGULAIR 54 36 107 77
EXELON 53 53 108 123
HYDRALAZINE HCL 53 42 108 107
NEXIUM 53 51 108 36
HUMULIN R 52 43 111 353
OXYBUTYNIN CHLORIDE ER 52 52 111 175
METOCLOPRAMIDE HCL 52 24 111 145
VENLAFAXINE HCL 51 21 114 267
GLUCAGEN 51 50 114 392
GLIMEPIRIDE 50 31 116 44
CARBAMAZEPINE 50 42 116 245
NOVOLOG 50 41 116 134
VENLAFAXINE HCL ER 50 25 116 178
BENAZEPRIL HCL 50 39 116 69
GENTAMICIN SULFATE 50 47 116 318
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.